Evogene Ltd.
NASDAQ:EVGN
1.27 (USD) • At close April 21, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 8.511 | 5.64 | 1.675 | 0.93 | 1.04 | 0.753 | 1.747 | 3.381 | 6.54 | 11.129 | 14.511 | 17.581 | 17.072 | 14.901 |
| Kosten van de omzet
| 2.683 | 4.241 | 0.909 | 0.767 | 0.574 | 0.334 | 1.452 | 2.845 | 5.639 | 8.255 | 9.709 | 10.114 | 9.552 | 8.247 |
| Brutowinst
| 5.828 | 1.399 | 0.766 | 0.163 | 0.466 | 0.419 | 0.295 | 0.536 | 0.901 | 2.874 | 4.802 | 7.467 | 7.52 | 6.654 |
| Brutowinstmarge
| 0.685 | 0.248 | 0.457 | 0.175 | 0.448 | 0.556 | 0.169 | 0.159 | 0.138 | 0.258 | 0.331 | 0.425 | 0.44 | 0.447 |
| Onderzoek- en ontwikkelingskosten
| 16.648 | 18.111 | 20.792 | 23.863 | 19.959 | 17.82 | 16.77 | 18.673 | 18.101 | 16.413 | 15.873 | 12.624 | 7.252 | 6.384 |
| Algemene en administratieve kosten
| 10.044 | 8.669 | 6.482 | 7.253 | 5.321 | 3.765 | 3.514 | 3.81 | 3.889 | 4.382 | 4.185 | 3.564 | 3.394 | 3.453 |
| Verkoop- en marketingkosten
| 0.822 | 1.01 | 3.933 | 0.653 | 0.52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 10.866 | 9.679 | 10.415 | 7.253 | 5.321 | 3.765 | 3.514 | 3.81 | 3.889 | 4.382 | 4.185 | 3.564 | 3.394 | 3.453 |
| Overige kosten
| 0.524 | 0 | -3.5 | 0 | 15.023 | -0.041 | -0.12 | -0.067 | -0.033 | 0 | -0.231 | -0.147 | -0.205 | -0.156 |
| Bedrijfskosten
| 28.038 | 27.79 | 27.707 | 31.116 | 25.28 | 21.585 | 20.284 | 22.483 | 21.99 | 20.795 | 20.058 | 16.188 | 10.646 | 9.837 |
| Bedrijfsresultaat
| -22.21 | -26.391 | -26.941 | -30.953 | -24.814 | -21.166 | -19.989 | -21.947 | -21.089 | -17.921 | -15.256 | -8.721 | -3.126 | -3.183 |
| Bedrijfsresultaat ratio
| -2.61 | -4.679 | -16.084 | -33.283 | -23.86 | -28.109 | -11.442 | -6.491 | -3.225 | -1.61 | -1.051 | -0.496 | -0.183 | -0.214 |
| Totaal overige inkomsten en kosten netto
| 4.165 | 0.404 | 0.687 | 0.521 | -1.36 | 2.075 | -0.793 | -1.725 | 1.533 | 0.708 | 0.726 | -0.157 | 0.678 | 3.828 |
| Inkomen voor belasting
| -18.045 | -25.987 | -29.754 | -30.432 | -26.174 | -19.091 | -20.782 | -20.827 | -19.556 | -17.213 | -14.53 | -8.878 | -2.448 | 0.645 |
| Inkomen voor belasting ratio
| -2.12 | -4.608 | -17.764 | -32.723 | -25.167 | -25.353 | -11.896 | -6.16 | -2.99 | -1.547 | -1.001 | -0.505 | -0.143 | 0.043 |
| Belastingkosten
| 0.009 | -0.033 | 0.09 | 0.013 | 0.032 | 0.024 | 0.03 | 0.011 | 0.036 | -2.197 | -1.8 | -1.67 | 0.074 | -3.828 |
| Nettowinst
| -16.485 | -23.879 | -26.638 | -27.793 | -23.374 | -18.112 | -20.758 | -20.838 | -19.592 | -17.213 | -14.53 | -8.878 | -2.522 | 0.645 |
| Nettowinstmarge
| -1.937 | -4.234 | -15.903 | -29.885 | -22.475 | -24.053 | -11.882 | -6.163 | -2.996 | -1.547 | -1.001 | -0.505 | -0.148 | 0.043 |
| WPA (Winst Per Aandeel)
| -2.89 | -5.23 | -6.46 | -6.87 | -8.3 | -0.7 | -0.81 | -0.81 | -0.77 | -0.68 | -0.58 | -0.45 | -0.14 | 0.04 |
| Verwaterde WPA
| -2.89 | -5.23 | -6.46 | -6.87 | -8.3 | -0.7 | -0.81 | -0.81 | -0.77 | -0.68 | -0.58 | -0.45 | -0.14 | 0.03 |
| EBITDA
| -15.478 | -23.204 | -26.933 | -27.795 | -23.178 | -15.968 | -18.621 | -18.553 | -18.81 | -15.488 | -13.007 | -7.204 | -1.291 | -1.764 |
| EBITDA ratio
| -1.819 | -4.114 | -16.079 | -29.887 | -22.287 | -21.206 | -10.659 | -5.487 | -2.876 | -1.392 | -0.896 | -0.41 | -0.076 | -0.118 |